LBA-2 Primary analysis of MOUNTAINEER: A phase 2 study of tucatinib and trastuzumab for HER2-positive mCRC

Jennifer Strickler, Andrea Cercek, Salvatore Siena, Thierry André, Kimmie Ng, E. Van Cutsem, Christina Wu, Andrew Scott Paulson, Joleen M. Hubbard, Andrew L. Coveler, Christos Fountzilas, Adel Kardosh, Pashtoon Murtaza Kasi, H. J. Lenz, Kristen K. Ciombor, E. Elez, David L. Bajor, Michael Stecher, Wentao Feng, Tanios Bekaii‐Saab